Crestor and Gastric polyps - a phase IV clinical study of FDA data

Summary:

Gastric polyps is reported as a side effect among people who take Crestor (rosuvastatin calcium), especially for people who are female, 60+ old, have been taking the drug for 10+ years also take Nexium, and have High blood pressure.

The phase IV clinical study analyzes which people have Gastric polyps when taking Crestor. It is created by eHealthMe based on reports of 143,349 people who have side effects when taking Crestor from the FDA, and is updated regularly.

What is Crestor?

Crestor has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 149,761 Crestor users. Check the latest studies of Crestor.

What is Gastric polyps?

Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane) is found to be associated with 460 drugs and 488 conditions by eHealthMe. Check the latest studies of Gastric polyps.

On Jul, 17, 2026

143,349 people reported to have side effects when taking Crestor.
Among them, 58 people (0.04%) have Gastric polyps.

Among these 58 people:

How long have people been on Crestor when they have Gastric polyps? *

What is the gender of people who have Gastric polyps when taking Crestor? *

female: 60.42 %
male: 39.58 %

What is the age of people who have Gastric polyps when taking Crestor? *

What are other drugs people take besides Crestor? *

What are other side effects people have besides Gastric polyps? *

Nausea (feeling of having an urge to vomit): 15 people, 25.86%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 18.97%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 10 people, 17.24%
Chest Pain: 9 people, 15.52%
Hypotension (abnormally low blood pressure): 8 people, 13.79%
Hyperkalemia (damage to or disease of the kidney): 8 people, 13.79%
High Blood Pressure: 8 people, 13.79%
Abdominal Discomfort: 7 people, 12.07%
Intestinal Obstruction: 7 people, 12.07%
Gallstones (stone formation by bile component): 7 people, 12.07%

What are the existing conditions these people have? *

High Blood Pressure: 14 people, 24.14%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 17.24%
Hyperlipidaemia (presence of excess lipids in the blood): 8 people, 13.79%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 6 people, 10.34%
Asthma: 6 people, 10.34%
Pain: 5 people, 8.62%
Insomnia (sleeplessness): 5 people, 8.62%
Muscle Spasms (muscle contraction): 5 people, 8.62%
Osteoporosis (bones weak and more likely to break): 5 people, 8.62%
Cardiac Disorder: 5 people, 8.62%

* Approximation only. Some reports may have incomplete information.

Do you take Crestor and have Gastric polyps?

- Check whether Gastric polyps is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Crestor:

Crestor (149,761 reports)

Gastric polyps treatments and more:

Gastric polyps (3,159 reports)

Browse all side effects of Crestor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastric polyps:

Gastric polyps (460 drugs)

Browse all the conditions that are associated with Gastric polyps:

Gastric polyps (488 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium (the active ingredients of Crestor) and Crestor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.